RADX Stock Analysis: Buy, Sell, or Hold?
RADX - Radiopharm Theranostics Limited American Depositary Shares
$4.15
-0.10 (-2.35%)
▼
5d:
-2.81%
30d:
-7.37%
90d:
-14.61%
HOLD
MODERATE Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Earnings: Feb 26, 2026
0d
Get Alerted When RADX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RADX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RADX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RADX is currently trading at $4.15, which is considered oversold relative to its 30-day fair value range of $4.33 to $4.64.
Technical Outlook: Technically, RADX is in a downtrend. The price is currently testing key support at $4.06. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RADX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $18.20 (+338.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RADX is in a downtrend. The price is currently testing key support at $4.06. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RADX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $18.20 (+338.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.33 -
$4.64
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 338.5% below Wall St target ($18.20)
Trading Range Analysis
30-Day Trading Range
$4.33 -
$4.64
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.06
Resistance Level
$4.75
Current Trend
Downtrend
Technical data as of
May 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.13
Wall Street Target
$18.20
(+338.5%)
Revenue Growth (YoY)
154.5%
Profit Margin
-286.2%
Share & Embed Analysis
Last updated: May 08, 2026 8:19 AM ET
Data refreshes hourly during market hours. Next update: 9:19 AM
Data refreshes hourly during market hours. Next update: 9:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RADX showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$408 | 63 BUY |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$230 | 53 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 63 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 61 BUY |
